Kalytera Therapeutics Inc Share Price Toronto S.E.
Equities
KLY
CA48349P1036
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- PTS | -.--% | -.--% | -.--% |
Sales 2019 | - | Sales 2020 | - | Capitalization | 1.37Cr 0 113.67Cr |
---|---|---|---|---|---|
Net income 2019 | -2.1Cr - -174.85Cr | Net income 2020 | 40L - 33Cr | EV / Sales 2019 | - |
Net Debt 2019 | 7L 0 5.86Cr | Net Debt 2020 | 9L 0 7.66Cr | EV / Sales 2020 | - |
P/E ratio 2019 |
-0.9
x | P/E ratio 2020 |
3.17
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 99.74% |
1st Jan change | Capi. | |
---|---|---|
-0.09% | 4.21TCr | |
+49.62% | 4.2TCr | |
-4.96% | 2.92TCr | |
+11.18% | 2.6TCr | |
-21.95% | 1.89TCr | |
+8.61% | 1.32TCr | |
+24.73% | 1.22TCr | |
+28.31% | 1.22TCr | |
-6.26% | 1.14TCr |
- Stock Market
- Equities
- CLAS.H Stock
- KLY Stock